1. Home
  2. EOD vs LFCR Comparison

EOD vs LFCR Comparison

Compare EOD & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOD
  • LFCR
  • Stock Information
  • Founded
  • EOD 2007
  • LFCR 1986
  • Country
  • EOD United States
  • LFCR United States
  • Employees
  • EOD N/A
  • LFCR N/A
  • Industry
  • EOD Investment Managers
  • LFCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • EOD Finance
  • LFCR Health Care
  • Exchange
  • EOD Nasdaq
  • LFCR Nasdaq
  • Market Cap
  • EOD 197.7M
  • LFCR 164.3M
  • IPO Year
  • EOD N/A
  • LFCR N/A
  • Fundamental
  • Price
  • EOD $4.86
  • LFCR $6.40
  • Analyst Decision
  • EOD
  • LFCR Buy
  • Analyst Count
  • EOD 0
  • LFCR 2
  • Target Price
  • EOD N/A
  • LFCR $8.00
  • AVG Volume (30 Days)
  • EOD 118.1K
  • LFCR 174.3K
  • Earning Date
  • EOD 01-01-0001
  • LFCR 10-04-2024
  • Dividend Yield
  • EOD 9.28%
  • LFCR N/A
  • EPS Growth
  • EOD N/A
  • LFCR N/A
  • EPS
  • EOD N/A
  • LFCR 0.17
  • Revenue
  • EOD N/A
  • LFCR $128,443,999.00
  • Revenue This Year
  • EOD N/A
  • LFCR $2.23
  • Revenue Next Year
  • EOD N/A
  • LFCR $8.40
  • P/E Ratio
  • EOD N/A
  • LFCR $44.60
  • Revenue Growth
  • EOD N/A
  • LFCR 23.42
  • 52 Week Low
  • EOD $3.73
  • LFCR $3.68
  • 52 Week High
  • EOD $4.71
  • LFCR $8.90
  • Technical
  • Relative Strength Index (RSI)
  • EOD 43.62
  • LFCR 58.32
  • Support Level
  • EOD $4.80
  • LFCR $5.56
  • Resistance Level
  • EOD $5.00
  • LFCR $7.23
  • Average True Range (ATR)
  • EOD 0.06
  • LFCR 0.35
  • MACD
  • EOD 0.00
  • LFCR 0.04
  • Stochastic Oscillator
  • EOD 30.00
  • LFCR 51.18

About EOD Allspring Global Dividend Opportunity Fund of Beneficial Interest

Allspring Global Dividend Opportunity Fund is a diversified closed-end management investment company. Its primary investment objective is to seek a high level of current income. The fund's secondary objective is the long-term growth of capital. The fund allocates its assets between two separate investment strategies or sleeves. Under normal market conditions, the fund allocates approximately 80% of its total assets to an equity sleeve comprised of common stocks.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.

Share on Social Networks: